Govt to release policy to improve bulk drug capacity: Subburaj
Other topics at the ASSOCHAM Pharma Summit included changes in drug pricing, the impending revision of NLEM-2011, and amendments…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Anti-fungal market: In High Gear
With growing awareness and understanding of fungal infections, India's anti fungal market is slated to grow phenomenally in the…
‘We are on track to serve 10,000 customers by mid 2015’
Preventive healthcare might be the buzzword, but a company down South is working towards a paradigm shift in personalised…
‘We are actively exploring the opportunity to address the Indian market’
Gabriel Perera, Director, Product Development and Business Development – Asia, Blackmores, talks about tropical diseases in India…
DoP declares 2015 as ‘Year of Active Pharmaceutical Ingredients’
BDMA in association with DoP will conduct following programmes. The '2015 - The Year of Active Pharmaceutical
Gavi releases figures of children vaccinated in the last 15 years
Half a billion children vaccinated: Gavi
US FDA bans imports from Ipca Labs plant in Madhya Pradesh
The US Food and Drug Administration (FDA) has banned imports from Indian generic drug maker Ipca Laboratories' plant at Ratlam in…
HBL launches cost effective Pentavalent & Hepatitis B vaccines
To roll vaccines for measles, BCG, rabies (Human), Japanese encephalitis and Hib for supplying to National Immunisation programme
Mylan to acquire Famy Care to create women’s healthcare franchise
The transaction is expected to close in the second half of 2015, subject to regulatory approvals and certain closing conditions
DoP visits USP India facility in Hyderabad
The visit aimed to understand the efforts USP is making in India to create standards for medicines, ensure full safety and quality…